ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1010

Post-Transplant Proteinuria Reduction Is Linked to Blood Pressure Improvement but Not Native Kidney Perfusion

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Kannenkeril, Dennis, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Kliem, Thorsten, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Heller, Katharina M., Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Bytyqi, Venera, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Striepe, Kristina, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Bosch, Agnes, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Martirosian, Petros, University Hospital of Tübingen, Tübingen, Germany
  • Janka, Rolf, Universitatsklinikum Erlangen Radiologisches Institut, Erlangen, BY, Germany
  • Uder, Michael, Universitatsklinikum Erlangen Radiologisches Institut, Erlangen, BY, Germany
  • Schmieder, Roland E., Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
  • Schiffer, Mario, Universitatsklinikum Erlangen Medizinische Klinik 4 Nephrologie und Hypertensiologie, Erlangen, BY, Germany
Background

An independent association between post-transplant proteinuria and cardiovascular risk was reported. In this study changes in proteinuria, renal perfusion of native kidneys and blood pressure were analyzed in patients following kidney transplantation (KTx).

Methods

Renal function (estimated glomerular filtration rate (eGFR), urinary albumin creatinine ratio (UACR)) and office blood pressure were assessed in patients with end-stage kidney stage of our living donor KTx program before and 2 months after KTx. Renal perfusion of the native kidneys was assessed in a sub-group of patients (n=14) using the arterial spin labeling MRI (ASL-MRI).

Results

The mean age of forty-two patients was 44.5 ± 14.8 years. eGFR at two months post-transplantation was 49.3 ± 15.2 ml/min/1.73 m2. Two months after KTx a relevant fall in UACR (2103.5 ± 2727.0 mg/g creatinine vs. 87.1 ± 109.9 mg/g creatinine; p < 0.001), office systolic blood pressure (136.7 ± 19.8 mmHg vs. 123.5 ± 12.3 mmHg; p < 0.001) and office diastolic blood pressure (85.3 ± 11.6 mmHg vs. 78.3 ± 9.5 mmHg; p < 0.001) were noticed compared to before KTx. A correlation was found between reduction in UACR and reduction in systolic blood pressure (r=0.446, p=0.009). A significant decrease of the perfusion of native kidneys was determined after KTx (table 1). No association was found between decrease of the perfusion of native kidneys and reduction in UACR after KTx.

Conclusion

Reduction in proteinuria following KTx was associated with reduction in blood pressure, but not with decrease in perfusion of the recipient native kidneys.

table 1
 Before KTx2-months after KTXp-value
Total renal perfusion (ml/100g/min)255.5 ± 26.5226.1 ± 35.5< 0.001
Cortex perfusion (ml/100g/min)
273.0 ± 29.9248.8 ± 30.70.002
Medulla perfusion (ml/100g/min)
247.8 ± 24.5208.6 ± 46.0< 0.001